<code id='007CEF923E'></code><style id='007CEF923E'></style>
    • <acronym id='007CEF923E'></acronym>
      <center id='007CEF923E'><center id='007CEF923E'><tfoot id='007CEF923E'></tfoot></center><abbr id='007CEF923E'><dir id='007CEF923E'><tfoot id='007CEF923E'></tfoot><noframes id='007CEF923E'>

    • <optgroup id='007CEF923E'><strike id='007CEF923E'><sup id='007CEF923E'></sup></strike><code id='007CEF923E'></code></optgroup>
        1. <b id='007CEF923E'><label id='007CEF923E'><select id='007CEF923E'><dt id='007CEF923E'><span id='007CEF923E'></span></dt></select></label></b><u id='007CEF923E'></u>
          <i id='007CEF923E'><strike id='007CEF923E'><tt id='007CEF923E'><pre id='007CEF923E'></pre></tt></strike></i>

          entertainment

          comprehensive

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Sudafed saga points to U.S. issues with evaluating older drugs
          Sudafed saga points to U.S. issues with evaluating older drugs

          PATRICKT.FALLON/AFPviaGettyImagesYouwouldhavebeenforgivenforbeingsurprisedonSept.12whenapanelofadvis

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Why Medicare shouldn’t cover every FDA

          AdobeWhoamongusislookingforwardtogettingolderin2024?Notsenators(mostofwhomare65andolder),thetwoleadi